HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kenji Chamoto Selected Research

1- cyclohexyl- N- (3- fluoro- 4- (4- methyl- 1- piperazinyl)phenyl)- 3- methyl- 1H- thieno(2,3- c)pyrazole- 5- carboxamide

10/2009Inhibition of phosphodiesterase 7A ameliorates Concanavalin A-induced hepatitis in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kenji Chamoto Research Topics

Disease

37Neoplasms (Cancer)
01/2021 - 04/2003
4Inflammation (Inflammations)
05/2011 - 02/2008
3Immune System Diseases (Immune Disorders)
01/2017 - 06/2003
3Carcinoma (Carcinomatosis)
04/2010 - 01/2007
3Lewis Lung Carcinoma
05/2009 - 01/2007
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 01/2016
2Wilms Tumor (Wilm's Tumor)
09/2015 - 07/2005
2Communicable Diseases (Infectious Diseases)
01/2015 - 02/2006
2Respiratory Hypersensitivity
06/2010 - 10/2004
2Sarcoma (Soft Tissue Sarcoma)
04/2010 - 08/2009
2Lymphoma (Lymphomas)
05/2009 - 01/2004
2Colitis
05/2008 - 12/2007
2Eosinophilia
02/2008 - 10/2004
2Leukemia
07/2005 - 04/2004
1Tuberculosis (Tuberculoses)
01/2021
1Infections
01/2020
1Hodgkin Disease (Hodgkin's Disease)
01/2020
1Chronic Hepatitis B
01/2020
1Dysbiosis
01/2020
1Virus Diseases (Viral Diseases)
01/2017
1Autoimmune Diseases (Autoimmune Disease)
01/2017
1Melanoma (Melanoma, Malignant)
01/2016
1Liver Failure
05/2011
1Diarrhea
05/2011
1Contact Dermatitis (Eczema, Contact)
11/2010
1Hepatitis
10/2009
1Lung Neoplasms (Lung Cancer)
02/2008
1Asthma (Bronchial Asthma)
02/2008
1Pulmonary Eosinophilia (Eosinophilic Pneumonia)
10/2004
1Graft vs Host Disease (Graft-Versus-Host Disease)
06/2004
1Crohn Disease (Crohn's Disease)
06/2003

Drug/Important Bio-Agent (IBA)

11OvalbuminIBA
06/2010 - 07/2003
11Neoplasm Antigens (Tumor Antigens)IBA
05/2009 - 07/2003
9AntigensIBA
01/2017 - 04/2003
6T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2021 - 10/2003
6CytokinesIBA
07/2010 - 04/2003
5Monoclonal AntibodiesIBA
11/2018 - 04/2003
5Interleukin-4 (Interleukin 4)IBA
10/2009 - 01/2004
4Immune Checkpoint InhibitorsIBA
01/2021 - 01/2016
4Biomarkers (Surrogate Marker)IBA
01/2021 - 04/2017
4LigandsIBA
01/2020 - 07/2010
4Proteins (Proteins, Gene)FDA Link
01/2020 - 12/2004
4Interleukin-6 (Interleukin 6)IBA
05/2011 - 12/2007
4Liposomes (Liposome)IBA
05/2009 - 09/2004
4Cancer VaccinesIBA
05/2009 - 07/2003
4Interleukin-12 (IL 12)IBA
02/2008 - 04/2003
3Peptides (Polypeptides)IBA
09/2015 - 01/2004
3Therapeutic UsesIBA
04/2010 - 08/2003
2Programmed Cell Death 1 ReceptorIBA
01/2021 - 01/2021
2NivolumabIBA
01/2020 - 01/2016
2Pharmaceutical PreparationsIBA
01/2016 - 10/2009
2AntibodiesIBA
01/2016 - 07/2010
2Interleukin-17 (Interleukin 17)IBA
07/2010 - 06/2010
2Transforming Growth Factor beta (TGF-beta)IBA
06/2010 - 04/2010
2Interleukin-13IBA
02/2008 - 10/2004
2CPG-oligonucleotideIBA
02/2008 - 03/2006
2OligodeoxyribonucleotidesIBA
02/2008 - 03/2006
2Interleukin-5 (Interleukin 5)IBA
02/2008 - 10/2004
1entecavirFDA Link
01/2020
1AMP-Activated Protein KinasesIBA
01/2020
1Immune Checkpoint ProteinsIBA
01/2020
1NucleosidesIBA
01/2020
1Oxygen (Dioxygen)IBA
01/2020
1Reverse Transcriptase InhibitorsIBA
01/2020
1Circular DNAIBA
01/2020
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
11/2018
1Transcription Factors (Transcription Factor)IBA
11/2018
1Fatty Acids (Saturated Fatty Acids)IBA
11/2018
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2017
1HLA Antigens (Human Leukocyte Antigens)IBA
09/2015
1AllergensIBA
11/2010
1Transforming Growth Factors (Transforming Growth Factor)IBA
04/2010
1DNA (Deoxyribonucleic Acid)IBA
04/2010
1Concanavalin AIBA
10/2009
1alpha-galactosylceramideIBA
10/2009
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
10/2009
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2009
11- cyclohexyl- N- (3- fluoro- 4- (4- methyl- 1- piperazinyl)phenyl)- 3- methyl- 1H- thieno(2,3- c)pyrazole- 5- carboxamideIBA
10/2009
1MethylcholanthreneIBA
08/2009
1VaccinesIBA
03/2006
1cytosine-phosphorothioate guanineIBA
03/2006
1HLA-A24 AntigenIBA
07/2005
1Interferon-gamma (Interferon, gamma)IBA
07/2005
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
04/2004
1HLA-DR Antigens (HLA-DR)IBA
04/2004
1Interleukin-3 (Interleukin 3)IBA
04/2004
1Interleukin-2 (IL2)IBA
02/2004
1Immunoglobulins (Immunoglobulin)IBA
02/2004
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2004

Therapy/Procedure

25Therapeutics
01/2021 - 07/2003
19Immunotherapy
01/2021 - 07/2003
4Radiotherapy
01/2016 - 01/2007
4Cell- and Tissue-Based Therapy (Cell Therapy)
02/2006 - 04/2003
3Drug Therapy (Chemotherapy)
04/2017 - 04/2010
2Subcutaneous Injections
08/2009 - 02/2008
1Aftercare (After-Treatment)
01/2020
1Transplantation
02/2008
1Ligation
12/2004
1Intranasal Administration
10/2004
1Hematopoietic Stem Cell Transplantation
06/2004